Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Circumcision LA Physician Dr. Padra Nourparvar Highlights 2026 Clinical Guidelines on Adult Circumcision for Phimosis

Dental Center of Jacksonville,

News provided by

Circumcision LA

Oct 23, 2026, 12:02 ET

Share this article

Share toX

Share this article

Share toX

New evidence-based guidance addresses the role of adult circumcision when chronic inflammatory skin disease causes persistent foreskin tightening that does not respond to medical treatment.

LOS ANGELES, Oct. 23, 2026 /PRNewswire/ -- Updated clinical guidelines published in 2026 are bringing renewed attention to the medical indications for adult circumcision, particularly among men experiencing pathological phimosis associated with lichen sclerosus, a chronic inflammatory skin condition. Dr. Padra Nourparvar, a board-certified family medicine physician and founder of Circumcision LA in Los Angeles, is highlighting the recommendations and the importance of accurate diagnosis and individualized treatment decisions.

Continue Reading
Circumcision LA
Circumcision LA

Published in the Journal der Deutschen Dermatologischen Gesellschaft, the evidence- and consensus-based guideline was developed by an interdisciplinary group of medical experts and professional societies in Germany, drawing on established European clinical guidance. It addresses the diagnosis, treatment, and long-term management of lichen sclerosus, including circumstances in which circumcision may be medically appropriate.

The guideline recommends circumcision for male patients whose phimosis is caused by lichen sclerosus and has not responded adequately to appropriate medical treatment, including prescription topical corticosteroids.

"Adult circumcision is often associated with personal, cultural, or religious preferences, but there are also recognized medical indications for the procedure," said Dr. Nourparvar. "Persistent foreskin tightening can cause discomfort, interfere with hygiene, and affect daily activities. Identifying the underlying cause is an important first step in determining whether medical treatment or circumcision may be appropriate."

Understanding Adult Phimosis and Lichen Sclerosus

Phimosis occurs when the foreskin cannot be fully retracted over the head of the penis. In adult men, acquired phimosis may develop because of chronic inflammation, scarring, or underlying skin conditions.

Symptoms can include foreskin tightness, discomfort, painful erections, recurrent irritation, and difficulty maintaining hygiene. In some cases, more advanced scarring may contribute to urinary symptoms.

Lichen sclerosus is one recognized cause of acquired pathological phimosis. The condition can affect genital skin, producing inflammation, changes in skin texture, and progressive scarring. Some patients may also develop involvement of the urinary opening or surrounding tissues.

Not every case of adult phimosis is caused by lichen sclerosus, and not every patient requires surgery.

"Men sometimes delay seeking medical evaluation because they assume foreskin tightness is simply a normal variation or a temporary irritation," Dr. Nourparvar explained. "Persistent symptoms deserve appropriate assessment, particularly when discomfort, inflammation, or progressive scarring is present."

What the 2026 Clinical Guidelines Recommend

The updated guideline identifies potent or ultrapotent topical corticosteroids as standard medical treatment for genital lichen sclerosus.

For male patients who develop phimosis associated with lichen sclerosus and do not respond sufficiently to appropriate medical therapy, the guideline recommends circumcision, preferably with complete removal of the affected foreskin.

The recommendations also address continued medical management, examination of removed tissue, and appropriate follow-up care.

Importantly, circumcision may relieve foreskin-related symptoms without necessarily eliminating the underlying inflammatory disease in every patient. Some individuals may require additional treatment or monitoring after surgery.

These recommendations reinforce the distinction between circumcision performed for personal reasons and circumcision considered for an established medical indication.

"Clinical guidelines are valuable because they help clarify when conservative treatment may be appropriate and when a surgical approach deserves consideration," said Dr. Nourparvar. "The decision should reflect the patient's diagnosis, symptoms, prior treatment response, and individual preferences."

Additional 2026 Research Examines Patient Outcomes

A separate 2026 study published in Frontiers in Medicine examined treatment outcomes and quality of life among 55 men with genital lichen sclerosus.

Of those participants, 40% had undergone circumcision. Researchers reported improved quality-of-life measures associated with circumcision, particularly among men experiencing phimosis.

However, some patients continued to require topical corticosteroid treatment following surgery, underscoring the chronic nature of lichen sclerosus and the importance of ongoing medical evaluation.

The researchers acknowledged limitations, including the study's retrospective design, relatively small patient population, and differences in individual treatment histories. Consequently, the findings do not establish that circumcision will produce the same results for every patient.

Together, the guideline and clinical study highlight the importance of matching treatment decisions to the underlying diagnosis rather than relying on a single approach for all patients.

Informed Decision-Making for Adult Circumcision

Adult circumcision may be considered for persistent pathological phimosis, certain recurrent inflammatory conditions, and other established medical indications.

As with any surgical procedure, circumcision involves potential risks, including bleeding, infection, wound-healing complications, scarring, and changes in sensation. Patients should receive information about these risks, appropriate pain management, recovery expectations, and available alternatives before making a treatment decision.

Dr. Nourparvar emphasizes that men experiencing persistent foreskin problems should undergo an appropriate medical evaluation to determine whether observation, medical therapy, specialist assessment, or circumcision is warranted.

"Not every patient with foreskin tightness needs surgery," Dr. Nourparvar said. "The goal is to understand the condition, explain the available treatment options, and help the patient make an informed decision based on medical evidence and individual circumstances."

The 2026 publications contribute to the clinical discussion surrounding adult phimosis and reinforce the role of circumcision as an established treatment option for selected patients when appropriate medical therapy has not adequately addressed the underlying problem.

About Dr. Padra Nourparvar and Circumcision LA

Dr. Padra Nourparvar is a board-certified family medicine physician and founder of Circumcision LA, a Los Angeles medical practice providing newborn, pediatric, adult, and revision circumcision services.

With more than a decade of clinical experience and additional training as a Mohel, Dr. Nourparvar provides circumcision services for patients with medical, personal, cultural, and religious considerations. His practice emphasizes individualized evaluation, informed consent, and appropriate procedural care.

For more information about adult circumcision, visit https://www.circumcisionla.com.

Media Contact

Dr. Padra Nourparvar
8631 West 3rd Street, Suite 545E
Los Angeles, CA 90048
(310) 361-5480
https://www.circumcisionla.com

SOURCE Circumcision LA

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Dr. Padra Nourparvar of Circumcision LA Named 2026 Top Patient Rated Los Angeles Family Medicine Doctor by Find Local Doctors

Dr. Padra Nourparvar of Circumcision LA Named 2026 Top Patient Rated Los Angeles Family Medicine Doctor by Find Local Doctors

Find Local Doctors, an online directory that connects patients with highly rated physicians, has named Dr. Padra Nourparvar, the board-certified...

Los Angeles Circumcision Revision Specialist Dr. Padra Nourparvar Raises Awareness of a Procedure Many Men Don't Know Exists

Los Angeles Circumcision Revision Specialist Dr. Padra Nourparvar Raises Awareness of a Procedure Many Men Don't Know Exists

Many men who were circumcised as infants or as adults are unaware that revision procedures exist to address an unsatisfactory outcome. Whether the...

More Releases From This Source

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Cosmetics and Personal Care

Cosmetics and Personal Care

Health Care & Hospitals

Health Care & Hospitals

Men's Interest

Men's Interest

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.